SCHEMBL30375516

SCHEMBL30375516

Clc1nnc(Cl)c2c1CCC2

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.32
NSD2 O96028 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ACHE P22303 1/20 0.31
KMT2A Q03164 1/20 0.31
BPTF Q12830 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL581560 1.00 MAPK1 (0.32) MAPK1NSD2KDM4EMEN1ACHE
SCHEMBL587789 0.93 MAPK1 (0.37) MAPK1NSD2KDM4EMEN1ACHE
SCHEMBL30932816 0.90 NSD2 (0.35) MAPK1NSD2KDM4EMEN1ACHE
SCHEMBL24379631 0.90 NSD2 (0.35) MAPK1NSD2KDM4EMEN1ACHE
SCHEMBL13534066 0.84 ACHE (0.33) MAPK1MEN1ACHEKMT2ABPTF
SCHEMBL30932856 0.84
SCHEMBL25404440 0.79
SCHEMBL1204218 0.79 GOT1 (0.41) KDM4E
SCHEMBL30932858 0.79 NSD2 (0.31) MAPK1NSD2
SCHEMBL24925903 0.75 NOS3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646197-A2 ORGANIC COMPOUNDS AS NLRP3 INHIBITORS Kodiak Sciences Inc. (US) 2025-11-12 EP disclosed
WO-2025034849-A1 FUSED PYRIDAZINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2025-02-13 WO disclosed
CN-119301116-A NLRP3 modulators 祖玛珍生物科学有限公司 2025-01-10 CN disclosed
WO-2024148029-A2 ORGANIC COMPOUNDS AS NLRP3 INHIBITORS KODIAK SCIENCES INC. (US) 2024-07-11 WO disclosed
CN-118234711-A Cyclopyridazine compounds 尼科治疗有限公司 2024-06-21 CN disclosed
CN-117881401-A NLRP3 modulators 祖玛珍生物科学有限公司 2024-04-12 CN disclosed
CN-116102535-A Nitrogen-containing compound, preparation method and application thereof 索智生物科技(浙江)有限公司 2023-05-12 CN disclosed